Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimer Dis Assoc Disord

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    May 2019
  1. AKUZAWA N, Yoshii A, Ono A, Kuwako T, et al
    Predictors of Discontinuance of Oral Feeding in Patients With Advanced Alzheimer Dementia and Aspiration Pneumonia in Japan: A Single-center, Retrospective Observational Study.
    Alzheimer Dis Assoc Disord. 2019 May 24. doi: 10.1097/WAD.0000000000000316.
    PubMed     Text format     Abstract available


  2. HATA K, Nakamoto K, Nunomura A, Sone D, et al
    Automated Volumetry of Medial Temporal Lobe Subregions in Mild Cognitive Impairment and Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2019 May 22. doi: 10.1097/WAD.0000000000000318.
    PubMed     Text format     Abstract available


  3. FAN J, Tse M, Carr JS, Miller BL, et al
    Alzheimer Disease-associated Cortical Atrophy Does not Differ Between Chinese and Whites.
    Alzheimer Dis Assoc Disord. 2019 May 13. doi: 10.1097/WAD.0000000000000315.
    PubMed     Text format     Abstract available


  4. GLOVER CM, CoCroft S, James BD, Barnes LL, et al
    Perceptions of Risk Factors for Alzheimer Disease Among Community-Dwelling, Nondemented Older African Americans.
    Alzheimer Dis Assoc Disord. 2019 May 1. doi: 10.1097/WAD.0000000000000314.
    PubMed     Text format     Abstract available


    April 2019
  5. CAI M, Guo Z, Xing G, Peng H, et al
    Transcranial Direct Current Stimulation Improves Cognitive Function in Mild to Moderate Alzheimer Disease: A Meta-Analysis.
    Alzheimer Dis Assoc Disord. 2019 Apr 24. doi: 10.1097/WAD.0000000000000304.
    PubMed     Text format     Abstract available


  6. GRILL JD, Nuno MM, Gillen DL
    Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?
    Alzheimer Dis Assoc Disord. 2019 Apr 4. doi: 10.1097/WAD.0000000000000303.
    PubMed     Text format     Abstract available


    February 2019
  7. TAKESHIMA N, Ishiwata K, Sozu T, Furukawa TA, et al
    Primary Endpoints in Current Phase II/III Trials for Alzheimer Disease: A Systematic Survey of Trials Registered at ClinicalTrials.gov.
    Alzheimer Dis Assoc Disord. 2019 Feb 5. doi: 10.1097/WAD.0000000000000297.
    PubMed     Text format     Abstract available


    January 2019
  8. ANDREWS SJ, McFall GP, Dixon RA, Cherbuin N, et al
    Alzheimer's Environmental and Genetic Risk Scores are Differentially Associated With General Cognitive Ability and Dementia Severity.
    Alzheimer Dis Assoc Disord. 2019 Jan 23. doi: 10.1097/WAD.0000000000000292.
    PubMed     Text format     Abstract available


  9. SQUITTI R, Mendez A, Ricordi C, Siotto M, et al
    Copper in Glucose Intolerance, Cognitive Decline, and Alzheimer's Disease.
    Alzheimer Dis Assoc Disord. 2019 Jan 10. doi: 10.1097/WAD.0000000000000280.
    PubMed     Text format     Abstract available


  10. BREGMAN N, Kave G, Mirelman A, Thaler A, et al
    Distinguishing Dementia With Lewy Bodies From Alzheimer's Disease: What is the Influence of the GBA Genotype in Ashkenazi Jews?
    Alzheimer Dis Assoc Disord. 2019 Jan 10. doi: 10.1097/WAD.0000000000000283.
    PubMed     Text format     Abstract available


  11. HAN JY, Besser LM, Xiong C, Kukull WA, et al
    Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
    Alzheimer Dis Assoc Disord. 2019 Jan 9. doi: 10.1097/WAD.0000000000000291.
    PubMed     Text format     Abstract available


    November 2018
  12. JAVAHERIAN K, Newman BM, Weng H, Hassenstab J, et al
    Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2018 Nov 26. doi: 10.1097/WAD.0000000000000284.
    PubMed     Text format     Abstract available


    October 2018
  13. BESSER L, Kukull W, Knopman DS, Chui H, et al
    Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.
    Alzheimer Dis Assoc Disord. 2018 Oct 29. doi: 10.1097/WAD.0000000000000279.
    PubMed     Text format     Abstract available


    September 2018
  14. ARBOLEDA-BUSTOS CE, Ortega-Rojas J, Mahecha MF, Arboleda G, et al
    The p.R47H Variant of TREM2 Gene is Associated With Late-onset Alzheimer Disease in Colombian Population.
    Alzheimer Dis Assoc Disord. 2018 Sep 14. doi: 10.1097/WAD.0000000000000275.
    PubMed     Text format     Abstract available


  15. GAGLIARDI S, Davin A, Bini P, Sinforiani E, et al
    A Novel Nonsense Angiogenin Mutation is Associated With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2018 Sep 4. doi: 10.1097/WAD.0000000000000272.
    PubMed     Text format    


    August 2018
  16. WELLS JL, Pasternak SH
    Case Report of a 63-Year-Old Patient With Alzheimer Disease and a Novel Presenilin 2 Mutation.
    Alzheimer Dis Assoc Disord. 2018 Aug 16. doi: 10.1097/WAD.0000000000000269.
    PubMed     Text format    


  17. KNAPSKOG AB, Braekhus A, Engedal K
    The Effect of Changing the Amyloid beta42 Cut-off of Cerebrospinal Fluid Biomarkers on Alzheimer Disease Diagnosis in a Memory Clinic Population in Norway.
    Alzheimer Dis Assoc Disord. 2018 Aug 13. doi: 10.1097/WAD.0000000000000268.
    PubMed     Text format    


    July 2018
  18. JIA X, Shi L, Qian T, Li Y, et al
    Improved Gray Matter Atrophy Detection in Alzheimer Disease in Chinese Populations Using Chinese Brain Template.
    Alzheimer Dis Assoc Disord. 2018 Jul 17. doi: 10.1097/WAD.0000000000000264.
    PubMed     Text format     Abstract available


    June 2018
  19. BARBER JM, Bardach SH, Jicha GA
    Alzheimer Disease Clinical Trial Recruitment: Does Participation in a Brief Cognitive Screen at a Community Health Fair Promote Research Engagement?
    Alzheimer Dis Assoc Disord. 2018 Jun 25. doi: 10.1097/WAD.0000000000000263.
    PubMed     Text format     Abstract available


  20. STITES SD, Harkins K, Rubright JD, Karlawish J, et al
    Relationships Between Cognitive Complaints and Quality of Life in Older Adults With Mild Cognitive Impairment, Mild Alzheimer Disease Dementia, and Normal Cognition.
    Alzheimer Dis Assoc Disord. 2018 Jun 25. doi: 10.1097/WAD.0000000000000262.
    PubMed     Text format     Abstract available


    May 2018
  21. GROSSBERG GT, Alva G, Hendrix S, Ellison N, et al
    Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors.
    Alzheimer Dis Assoc Disord. 2018 May 16. doi: 10.1097/WAD.0000000000000261.
    PubMed     Text format     Abstract available


  22. BAHIA VS, Cecchini MA, Cassimiro L, Viana R, et al
    The Accuracy of INECO Frontal Screening in the Diagnosis of Executive Dysfunction in Frontotemporal Dementia and Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2018 May 4. doi: 10.1097/WAD.0000000000000255.
    PubMed     Text format     Abstract available


    April 2018
  23. PIERCE AL, Cox CG, Nguyen H, Hoang D, et al
    Participant Satisfaction With Learning Alzheimer Disease Clinical Trial Results.
    Alzheimer Dis Assoc Disord. 2018 Apr 20. doi: 10.1097/WAD.0000000000000258.
    PubMed     Text format    


    March 2018
  24. ALLISON S, Babulal GM, Stout SH, Barco PP, et al
    Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities.
    Alzheimer Dis Assoc Disord. 2018 Mar 23. doi: 10.1097/WAD.0000000000000257.
    PubMed     Text format     Abstract available


  25. BRADFIELD NI, Ellis KA, Savage G, Maruff P, et al
    Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.
    Alzheimer Dis Assoc Disord. 2018 Mar 20. doi: 10.1097/WAD.0000000000000252.
    PubMed     Text format     Abstract available


  26. LADEIRA F, Cacao G, Correia AP, Pinto PS, et al
    When Decrease Abeta1-42 in CSF May Not Mean Alzheimer's Disease: Insights From Two Case Reports With Early Onset Dementia.
    Alzheimer Dis Assoc Disord. 2018 Mar 9. doi: 10.1097/WAD.0000000000000248.
    PubMed     Text format    


    January 2018
  27. GABEL M, Gooblar J, Roe CM, Selsor NJ, et al
    Political Ideology, Confidence in Science, and Participation in Alzheimer Disease Research Studies.
    Alzheimer Dis Assoc Disord. 2018 Jan 18. doi: 10.1097/WAD.0000000000000244.
    PubMed     Text format     Abstract available


  28. MILAN-TOMAS A, Shapiro CM
    Circadian Rhythms Disturbances in Alzheimer Disease: Current Concepts, Diagnosis, and Management.
    Alzheimer Dis Assoc Disord. 2018 Jan 18. doi: 10.1097/WAD.0000000000000243.
    PubMed     Text format     Abstract available


    December 2017
  29. SOUSA MFB, Santos RL, Simoes P, Conde-Sala JL, et al
    Discrepancies Between Alzheimer's Disease Patients' and Caregivers' Ratings About Patients' Quality of Life: A 1-year Observation Study in Brazil.
    Alzheimer Dis Assoc Disord. 2017 Dec 27. doi: 10.1097/WAD.0000000000000232.
    PubMed     Text format     Abstract available


  30. WEINTRAUB S, Besser L, Dodge HH, Teylan M, et al
    Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS).
    Alzheimer Dis Assoc Disord. 2017 Dec 13. doi: 10.1097/WAD.0000000000000223.
    PubMed     Text format     Abstract available


    November 2017
  31. TENSIL M, Hessler JB, Gutsmiedl M, Riedl L, et al
    Sex Differences in Neuropsychological Test Performance in Alzheimer's Disease and the Influence of the ApoE Genotype.
    Alzheimer Dis Assoc Disord. 2017 Nov 17. doi: 10.1097/WAD.0000000000000229.
    PubMed     Text format     Abstract available


    October 2017
  32. LACERDA IB, Santos RL, Neto JPS, Dourado MCN, et al
    Factors Related to Different Objects of Awareness in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017;31:335-342.
    PubMed     Text format     Abstract available


    September 2017
  33. MOULDER KL, Besser LM, Beekly D, Blennow K, et al
    Factors Influencing Successful Lumbar Puncture in Alzheimer Research.
    Alzheimer Dis Assoc Disord. 2017 Sep 7. doi: 10.1097/WAD.0000000000000209.
    PubMed     Text format     Abstract available


    August 2017
  34. PANEGYRES PK, Goh J, McCarthy M, Campbell AI, et al
    The Nature and Natural History of Posterior Cortical Atrophy Syndrome: A Variant of Early-onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 Aug 8. doi: 10.1097/WAD.0000000000000207.
    PubMed     Text format     Abstract available


  35. ZADORI D, Fuvesi J, Timar E, Horvath E, et al
    The Report of p.Val717Phe Mutation in the APP Gene in a Hungarian Family With Alzheimer Disease: A Phenomenological Study.
    Alzheimer Dis Assoc Disord. 2017 Aug 8. doi: 10.1097/WAD.0000000000000206.
    PubMed     Text format    


    June 2017
  36. STONNINGTON CM, Harel B, Locke DEC, Hentz JG, et al
    Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 Jun 2. doi: 10.1097/WAD.0000000000000200.
    PubMed     Text format     Abstract available


    May 2017
  37. AZAR M, Zhu C, DeFeis B, Gu Y, et al
    Increased Reporting Accuracy of Alzheimer Disease Symptoms in Caribbean Hispanic Informants.
    Alzheimer Dis Assoc Disord. 2017 May 26. doi: 10.1097/WAD.0000000000000199.
    PubMed     Text format     Abstract available


  38. MICHAUD TL, High R, Charlton ME, Murman DL, et al
    Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 May 8. doi: 10.1097/WAD.0000000000000198.
    PubMed     Text format     Abstract available


    April 2017
  39. DAY GS, Gordon BA, Jackson K, Christensen JJ, et al
    Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia.
    Alzheimer Dis Assoc Disord. 2017 Apr 7. doi: 10.1097/WAD.0000000000000196.
    PubMed     Text format     Abstract available


  40. KOENIG AM, Mechanic-Hamilton D, Xie SX, Combs MF, et al
    Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study.
    Alzheimer Dis Assoc Disord. 2017;31:107-113.
    PubMed     Text format     Abstract available


    March 2017
  41. MORENO DJ, Pino S, Rios A, Lopera F, et al
    Genetic Ancestry and Susceptibility to Late-Onset Alzheimer's Disease (LOAD) in the Admixed Colombian Population.
    Alzheimer Dis Assoc Disord. 2017 Mar 31. doi: 10.1097/WAD.0000000000000195.
    PubMed     Text format     Abstract available


  42. OPOKU ST, Apenteng BA, Lin G
    Temporal Trends and Rural-Urban Differences in Hospital Length of Stay for Alzheimer Disease and Related Disorders.
    Alzheimer Dis Assoc Disord. 2017 Mar 14. doi: 10.1097/WAD.0000000000000183.
    PubMed     Text format     Abstract available


    January 2017
  43. VELAYOS-BAEZA A, Danek A
    Chorein Deficiency and Alzheimer Disease: An Intriguing, Yet Premature Speculation.
    Alzheimer Dis Assoc Disord. 2017 Jan 24. doi: 10.1097/WAD.0000000000000186.
    PubMed     Text format    


  44. LAZARCZYK MJ, Haller S, Savioz A, Gimelli S, et al
    Heterozygous Deletion of Chorein Exons 70-73 and GNA14 Exons 3-7 in a Brazilian Patient Presenting With Probable Tau-Negative Early-Onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 Jan 10. doi: 10.1097/WAD.0000000000000185.
    PubMed     Text format    


    December 2016
  45. PARK SA, Chae WS, Kim HJ, Shin HS, et al
    Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea.
    Alzheimer Dis Assoc Disord. 2016 Dec 23. doi: 10.1097/WAD.0000000000000184.
    PubMed     Text format     Abstract available


  46. RITTER AR, Leger GC, Miller JB, Banks SJ, et al
    Neuropsychological Testing in Pathologically Verified Alzheimer Disease and Frontotemporal Dementia: How Well Do the Uniform Data Set Measures Differentiate Between Diseases?
    Alzheimer Dis Assoc Disord. 2016 Dec 21. doi: 10.1097/WAD.0000000000000181.
    PubMed     Text format     Abstract available


    November 2016
  47. TREBBASTONI A, Marcelli M, Mallone F, D'Antonio F, et al
    Attenuation of Choroidal Thickness in Patients With Alzheimer Disease: Evidence From an Italian Prospective Study.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  48. SUGIMOTO T, Ono R, Murata S, Saji N, et al
    Sarcopenia is Associated With Impairment of Activities of Daily Living in Japanese Patients With Early-Stage Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


  49. MONSELL SE, Mock C, Fardo DW, Bertelsen S, et al
    Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  50. DEVANAND DP, Pelton GH, D'Antonio K, Strickler JG, et al
    Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


  51. VERHULSDONK S, Lange-Asschenfeldt C, Hoft B, Schwender H, et al
    Repressive Coping Does Not Contribute to Anosognosia in First-Diagnosis Patients With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  52. DE LUCIA N, Grossi D, Trojano L
    Closing-in is Related to Daily Living Functioning in Patients With Mild-to-Moderate Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


    October 2016
  53. PRUZIN JJ, Schneider JA, Capuano AW, Leurgans SE, et al
    Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  54. ZUCCHELLA C, Bartolo M, Bernini S, Picascia M, et al
    Modeling Alzheimer's Disease Through Functional Independence and Participation.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


    September 2016
  55. LAGARDE J, Sarazin M, Chauvire V, Stankoff B, et al
    Cholinergic Changes in Aging and Alzheimer Disease: An [18F]-F-A-85380 Exploratory PET Study.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


    January 2016
  56. GERSTENECKER A, Triebel KL, Martin R, Snyder S, et al
    Both Financial and Cognitive Decline Predict Clinical Progression in MCI.
    Alzheimer Dis Assoc Disord. 2016;30:27-34.
    PubMed     Text format     Abstract available


  57. WALTER S, Marden JR, Kubzansky LD, Mayeda ER, et al
    Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study.
    Alzheimer Dis Assoc Disord. 2016;30:15-20.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: